Rodriguez-Gutierrez Rene, Salcido-Montenegro Alejandro, Singh-Ospina Naykky M, Maraka Spyridoula, Iñiguez-Ariza Nicole, Spencer-Bonilla Gabriela, Tamhane Shrikant U, Lipska Kasia J, Montori Victor M, McCoy Rozalina G
Knowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic, Rochester, MN, 55905, USA.
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Endocrine. 2020 Mar;67(3):552-560. doi: 10.1007/s12020-019-02147-w. Epub 2019 Dec 4.
To examine the proportion of diabetes-focused clinical encounters in primary care and endocrinology practices where the evaluation for hypoglycemia is documented; and when it is, identify clinicians' stated actions in response to patient-reported events.
A total of 470 diabetes-focused encounters among 283 patients nonpregnant adults (≥18 years) with type 1 or type 2 diabetes mellitus in this retrospective cohort study. Participants were randomly identified in blocks of treatment strategy and care location (95 and 52 primary care encounters among hypoglycemia-prone medications (i.e. insulin, sulfonylurea) and others patients, respectively; 94 and 42 endocrinology encounters among hypo-treated and others, respectively). Documentation of hypoglycemia and subsequent management plan in the electronic health record were evaluated.
Overall, 132 (46.6%) patients had documentation of hypoglycemia assessment, significantly more prevalent among hypo-treated patients seen in endocrinology than in primary care (72.3% vs. 47.4%; P = 0.001). Hypoglycemia was identified by patient in 38.2% of encounters. Odds of hypoglycemia assessment documentation was highest among the hypo-treated (OR 13.6; 95% CI 5.5-33.74, vs. others) and patients seen in endocrine clinic (OR 4.48; 95% CI 2.3-8.6, vs. primary care). After documentation of hypoglycemia, treatment was modified in 30% primary care and 46% endocrine clinic encounters; P = 0.31. Few patients were referred to diabetes self-management education and support (DSMES).
Continued efforts to improve hypoglycemia evaluation, documentation, and management are needed, particularly in primary care. This includes not only screening at-risk patients for hypoglycemia, but also modifying their treatment regimens and/or leveraging DSMES.
研究在初级保健和内分泌科诊疗中,记录有低血糖评估的以糖尿病为重点的临床会诊比例;若有记录,则确定临床医生针对患者报告事件所采取的既定行动。
在这项回顾性队列研究中,共纳入了283例1型或2型糖尿病非妊娠成人(≥18岁)的470次以糖尿病为重点的会诊。参与者按治疗策略和护理地点分组随机确定(分别有95次和52次初级保健会诊,其中使用易致低血糖药物(即胰岛素、磺脲类药物)的患者和其他患者各占一部分;分别有94次和42次内分泌科会诊,其中接受过低血糖治疗的患者和其他患者各占一部分)。评估电子健康记录中低血糖及后续管理计划的记录情况。
总体而言,132例(46.6%)患者有低血糖评估记录,在内分泌科接受过低血糖治疗的患者中比在初级保健中更为普遍(72.3%对47.4%;P = 0.001)。在38.2%的会诊中患者自行发现低血糖。低血糖评估记录的几率在接受过低血糖治疗的患者中最高(比值比13.6;95%置信区间5.5 - 33.74,与其他患者相比)以及在内分泌科就诊的患者中(比值比4.48;95%置信区间2.3 - 8.6,与初级保健相比)。记录低血糖后,30%的初级保健会诊和46%的内分泌科会诊中治疗方案进行了调整;P = 0.31。很少有患者被转介接受糖尿病自我管理教育与支持(DSMES)。
需要持续努力改善低血糖评估、记录和管理,尤其是在初级保健中。这不仅包括对有低血糖风险的患者进行筛查,还包括调整他们的治疗方案和/或利用糖尿病自我管理教育与支持。